Eduardo Mysler
机构:Universidad Autónoma de la Ciudad de México, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno · ORCID:0000-0002-8993-0313
发表论文 165 篇 · 总被引 19928 次 · h-index 41
代表论文
- B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment (2025 · Annals of the Rheumatic Diseases · 被引 13)
- Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities (2024 · Kidney International Reports · 被引 10)
- Rheumatoid arthritis in Latin America: pharmacotherapy and clinical challenges (2024 · Expert Opinion on Pharmacotherapy · 被引 9)
- Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy (2025 · RMD Open · 被引 6)
- Benefit–risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease (2025 · RMD Open · 被引 6)
- Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis (2025 · The Lancet Rheumatology · 被引 4)